QURE platform is unbelievably cheap at these levels
The PR was very weak and WAY too many retail investors got caught up in this stock thinking PT's would be walking on water by now. The more retail drama that gets pushed out of this stock the better in my opinion.
Coming from the guy whom said BLUE would never hit $160 ever again, then , 30 minutes later it was at $162. I think your prophecies lack any merit.
I'm in other GT stocks and was hoping this would squeeze buy with some positive results. Tomorrow is going to hurt really bad for this stock. Been there before so keep your head up and move on.
BLUE has a 'tool kit" (gene editing) to work around such issues with their CAR-T program. That's why they are pretty bold in saying that they will lead the CAR-T space.
I get it. But look at companies like Bluebird bio. They gave a PT with sickle cell disease a potentially curative treatment and that person has been kept completely under raps. The ENTIRE biotech community wants to know about this one PT.
I called NVIV on this, as I was concerned about it becoming a SRPT. PT vids, charities, news coverage are great but it's the data that tends to lag. I for one was hoping they could lock up some non disclosure agreement. But if they need to raise money I can understand that's tough to enforce
This was a topic that I thought the board was too crazy to understand. I was really questioning the 503 as well.
This is the best advice this board has ever seen.